Viability and apoptosis measured by imaging in BRAF(V600E/D) melanoma cell lines following treatment with combinations of two compounds (viability/apoptosis dataset 1 of 2) - Dataset (ID:20272)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule 1 | Small Molecule 2 | Small Mol 1 Concentration | Small Mol 2 Concentration | Small Mol Conc Unit | Time Point | Time Point Unit | Replicate | Total Number of Cells (Nuclei) | Number of Apoptotic Cells | Relative Viability | Mean Relative Viability | Apoptosis Fraction | Mean Apoptosis Fraction |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
MZ7-mel | Vemurafenib | PF562271 | 1.000 | 3.160 | uM | 72 | hr | 1 | 1239 | 114 | 0.3246 | 0.2591 | 0.0920 | 0.0924 |
MZ7-mel | Vemurafenib | PF562271 | 1.000 | 3.160 | uM | 72 | hr | 2 | 1016 | 94 | 0.2660 | 0.2591 | 0.0925 | 0.0924 |
MZ7-mel | Vemurafenib | PF562271 | 1.000 | 3.160 | uM | 72 | hr | 3 | 713 | 66 | 0.1867 | 0.2591 | 0.0926 | 0.0924 |
MZ7-mel | Vemurafenib | PF562271 | 3.160 | 0.000 | uM | 72 | hr | 1 | 1194 | 304 | 0.2568 | 0.3102 | 0.2546 | 0.2845 |
MZ7-mel | Vemurafenib | PF562271 | 3.160 | 0.000 | uM | 72 | hr | 2 | 1597 | 449 | 0.3312 | 0.3102 | 0.2812 | 0.2845 |
MZ7-mel | Vemurafenib | PF562271 | 3.160 | 0.000 | uM | 72 | hr | 3 | 1741 | 553 | 0.3427 | 0.3102 | 0.3176 | 0.2845 |
MZ7-mel | Vemurafenib | PF562271 | 3.160 | 0.316 | uM | 72 | hr | 1 | 585 | 88 | 0.1434 | 0.1862 | 0.1504 | 0.1658 |
MZ7-mel | Vemurafenib | PF562271 | 3.160 | 0.316 | uM | 72 | hr | 2 | 878 | 144 | 0.2118 | 0.1862 | 0.1640 | 0.1658 |
MZ7-mel | Vemurafenib | PF562271 | 3.160 | 0.316 | uM | 72 | hr | 3 | 863 | 158 | 0.2034 | 0.1862 | 0.1831 | 0.1658 |
MZ7-mel | Vemurafenib | PF562271 | 3.160 | 1.000 | uM | 72 | hr | 1 | 1771 | 249 | 0.4391 | 0.3063 | 0.1406 | 0.1700 |
MZ7-mel | Vemurafenib | PF562271 | 3.160 | 1.000 | uM | 72 | hr | 2 | 1364 | 241 | 0.3240 | 0.3063 | 0.1767 | 0.1700 |
MZ7-mel | Vemurafenib | PF562271 | 3.160 | 1.000 | uM | 72 | hr | 3 | 669 | 129 | 0.1558 | 0.3063 | 0.1928 | 0.1700 |
MZ7-mel | Vemurafenib | PF562271 | 3.160 | 3.160 | uM | 72 | hr | 1 | 925 | 144 | 0.2253 | 0.1873 | 0.1557 | 0.1549 |
MZ7-mel | Vemurafenib | PF562271 | 3.160 | 3.160 | uM | 72 | hr | 2 | 729 | 119 | 0.1760 | 0.1873 | 0.1632 | 0.1549 |
MZ7-mel | Vemurafenib | PF562271 | 3.160 | 3.160 | uM | 72 | hr | 3 | 652 | 95 | 0.1607 | 0.1873 | 0.1457 | 0.1549 |
MZ7-mel | Vemurafenib | Saracatinib | 0.000 | 0.000 | uM | 72 | hr | 1 | 3049 | 224 | 0.9214 | 1.0000 | 0.0735 | 0.0654 |
MZ7-mel | Vemurafenib | Saracatinib | 0.000 | 0.000 | uM | 72 | hr | 2 | 3491 | 225 | 1.0652 | 1.0000 | 0.0645 | 0.0654 |
MZ7-mel | Vemurafenib | Saracatinib | 0.000 | 0.000 | uM | 72 | hr | 3 | 3299 | 192 | 1.0134 | 1.0000 | 0.0582 | 0.0654 |
MZ7-mel | Vemurafenib | Saracatinib | 0.000 | 0.316 | uM | 72 | hr | 1 | 2761 | 200 | 0.8353 | 1.4168 | 0.0724 | 0.0618 |
MZ7-mel | Vemurafenib | Saracatinib | 0.000 | 0.316 | uM | 72 | hr | 2 | 4806 | 288 | 1.4736 | 1.4168 | 0.0599 | 0.0618 |
MZ7-mel | Vemurafenib | Saracatinib | 0.000 | 0.316 | uM | 72 | hr | 3 | 6287 | 334 | 1.9416 | 1.4168 | 0.0531 | 0.0618 |
MZ7-mel | Vemurafenib | Saracatinib | 0.000 | 1.000 | uM | 72 | hr | 1 | 2708 | 151 | 0.8340 | 0.7361 | 0.0558 | 0.0573 |
MZ7-mel | Vemurafenib | Saracatinib | 0.000 | 1.000 | uM | 72 | hr | 2 | 2625 | 125 | 0.8154 | 0.7361 | 0.0476 | 0.0573 |
MZ7-mel | Vemurafenib | Saracatinib | 0.000 | 1.000 | uM | 72 | hr | 3 | 1840 | 126 | 0.5590 | 0.7361 | 0.0685 | 0.0573 |
MZ7-mel | Vemurafenib | Saracatinib | 0.000 | 3.160 | uM | 72 | hr | 1 | 4872 | 354 | 1.4736 | 0.9734 | 0.0727 | 0.0805 |